Navigation Links
Eularis Releases Update of Its Comprehensive Report on Maximizing the Bottom Line in Pharmaceutical Marketing
Date:10/30/2007

NEW YORK and LONDON, Oct. 30 /PRNewswire/ -- Eularis is announcing the release of an update to its report, "Ensuring Profitable Return-on-Investment (ROI) in Pharmaceutical Marketing: Using Analytics and Metrics to Improve the Bottom Line." Originally offered in February 2007, the comprehensive report has been revised to provide pharmaceutical marketers with a competitive edge and the latest research information.

*(LOGO 72dpi: Send2Press.com/mediaboom/07-0924-Eularis_72dpi.jpg)

"The pharmaceutical environment is turbulent, and what used to work to create an industry-wide growth of 20 percent, no longer does," said the author of the report, Dr. Andree K. Bates, president of Eularis. "As market growth slows, the bottom line return for brands is under increased scrutiny, and every marketing dollar must count."

Eularis identified a common problem faced by pharmaceutical companies -- how to know which activities impact market share and by how much. The company assembled a group of world-leading mathematicians in the predictive analytics field, as well as thought leaders, to find the solution.

This report, in turn, analyzes how top pharmaceutical marketing leaders are handling pressing marketing return issues, and offers new ideas to apply. The detailed research addresses issues such as: ROI basics; practical skills marketers need for measuring marketing effectiveness; tools and best practices that make a difference; measurement principles that drive successful marketing measurement; how to propel strategy, growth, and bottom line return; plus an array of case studies.

The report also explains what real people did to measure, improve, and prove bottom line return. It uncovers practices to predict how and where pharmaceutical marketing and sales investments will yield the highest market share and market share price. Readers will benefit from the step-by-step guidelines on successfully implementing approaches for real and measurable results available only in this report.

Dr. Andree Bates, president of Eularis, has gained wide recognition within the international pharmaceutical industry for her expertise in marketing return analysis and is the author of this must-have report for all pharmaceutical industry marketers.

To purchase this report, visit: http://www.pharmamarketingroi.com.

About Eularis

Eularis provides sophisticated pharmaceutical analytics that provide data-driven insight into the financial impact of corporate and marketing decisions. Unlike traditional analytics approaches which are lengthy and whose reliance on historical or analogue data reduces their accuracy, Eularis' proprietary 94.8 Analytics Process is based on the current market situation. This proven approach helps pharmaceutical marketing teams to quickly plan, measure, validate, and optimize their sales and marketing performance. Eularis offers pre-launch analytics, marketing mix modeling (both professional and consumer), portfolio optimization, sales force effectiveness, managed care analytics, and patient compliance solutions. Co-headquartered in London and New York City, the company has developed significant experience in the global pharmaceutical market through client engagements with AstraZeneca, GlaxoSmithKline, Merck, Pfizer and many others.

For more information about Eularis, visit http://www.eularis.com.

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com


'/>"/>
SOURCE Eularis
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Sweet corn releases antioxidants on cooking
2. An International Growth Standard For Childs Releases By WHO
3. The National Governors Association Releases Guidelines For Outbreak Of Bird Flu
4. Eli Lilly Releases Digital Insulin Pen
5. WHO Updates Outdated Pediatric Growth Charts
6. High -tech Mitochondrial DNA Sequencing Tool Updated
7. Updated Sleep Apnea Screening Recommended for Commercial Drivers
8. Warning on Avastin Updated
9. NanoSensors Provides Update on Its Biosensor to Detect E.coli and Salmonella
10. A Comprehensive CD-ROM On HIV/AIDS Released By Center for HIV Information
11. ‘Comprehensive Sex Education’ Favored Against ‘Abstinence-Only’ Progams
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... been named one of Michigan’s 2017 Best and Brightest in Wellness® by Best ... in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: ... that developed an innovative way to use nonlinear optical ... delivery of new drugs. ... Dermatology Conference will show how researchers from BioPharmX and ... Medical School used a suite of imaging techniques in ...
(Date:10/11/2017)... 11, 2017  True Health, a leader in ... effort during National Breast Cancer Awareness month to ... Research recently ... that more than 10 million American women are ... BRCA1 or BRCA2 and have not had testing. These ...
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
Breaking Medicine Technology: